PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 20019189-0 2010 Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis. Iron 0-4 tumor protein p53 Homo sapiens 45-48 20019189-4 2010 Iron dependent regulation of MDM2/p53 was confirmed ex-vivo in human monocytes, by manipulation of iron pool and in a genetic model of iron deficiency, leading to modulation of p53 target genes involved in the antioxidant response and apoptosis. Iron 0-4 tumor protein p53 Homo sapiens 34-37 20019189-4 2010 Iron dependent regulation of MDM2/p53 was confirmed ex-vivo in human monocytes, by manipulation of iron pool and in a genetic model of iron deficiency, leading to modulation of p53 target genes involved in the antioxidant response and apoptosis. Iron 0-4 tumor protein p53 Homo sapiens 177-180 20019189-4 2010 Iron dependent regulation of MDM2/p53 was confirmed ex-vivo in human monocytes, by manipulation of iron pool and in a genetic model of iron deficiency, leading to modulation of p53 target genes involved in the antioxidant response and apoptosis. Iron 99-103 tumor protein p53 Homo sapiens 34-37 20019189-5 2010 Iron status influenced p53 ubiquitination and degradation rate, and the MDM2 inhibitor nutlin increased p53 levels in iron-depleted cells. Iron 0-4 tumor protein p53 Homo sapiens 23-26 20019189-5 2010 Iron status influenced p53 ubiquitination and degradation rate, and the MDM2 inhibitor nutlin increased p53 levels in iron-depleted cells. Iron 118-122 tumor protein p53 Homo sapiens 104-107 20019189-7 2010 The MDM2 -309T > G promoter polymorphism, determining increased MDM2 and lower p53 activity, was associated with higher risk of hepatocarcinoma in cirrhotic patients with hemochromatosis, and with HFE mutations in patients with hepatocarcinoma without hemochromatosis, suggesting an interaction between MDM2 and iron in the pathogenesis of hepatocarcinoma. Iron 315-319 tumor protein p53 Homo sapiens 82-85 20019189-8 2010 In conclusion, iron status influences p53 activity and antioxidant response by modulating MDM2 expression. Iron 15-19 tumor protein p53 Homo sapiens 38-41